BMC Nephrology Submission Guide

Worked example

A weak biomarker manuscript says a plasma marker predicts CKD progression. A stronger submission defines progression, shows the time horizon, explains missing data and competing risks, reports calibration and incremental value over current predictors, and states whether the result supports risk stratification, hypothesis generation, or a clinical decision.

Select the reporting guideline from the design, not the conclusion you hope to make.

• Use CONSORT and the current trial record for randomized trials.
• Use STROBE for observational studies.
• Use PRISMA for systematic reviews.
• Use STARD for diagnostic-accuracy studies.
• Use TRIPOD or the current applicable prediction-model guidance for prediction studies.
• Use ARRIVE for in vivo animal work where applicable.
• Use CARE for case reports when that article type is available.

Include the completed checklist and flow diagram where the live submission route asks for them. A checklist is not a substitute for clear methods; it is a map that helps editors and reviewers find the evidence.

Start with the clinical or biological problem, then show why this design can resolve part of it. A readable dependency sequence is:

1. Define the kidney-disease population, process, or decision.
2. Name the uncertainty in current evidence or care.
3. Explain why the chosen design can reduce that uncertainty.
4. Present the primary result with absolute scale and uncertainty.
5. Separate what the study establishes from what requires validation.
6. Return to the decision, mechanism, or next study the result changes.

This prevents a common failure: a detailed methods section attached to an abstract that promises more clinical utility than the study tested.

For human research, state the approving body, approval identifier where applicable, consent route, and any waiver with its basis. Protect patient privacy in text, figures, imaging, pedigrees, and supplements. For case material, follow the live consent instructions.

The data availability statement should say what exists, where it can be accessed, and which ethical or legal limits apply. For sensitive health data, “available on request” is only useful when the request route, decision maker, eligibility, and restrictions are explained.

Use the live Springer Nature page to confirm the article type and upload route. Prepare:

• the main manuscript with tables and figures placed as instructed;
• a title page and anonymized file if the selected review route requires separation;
• reporting checklist and flow diagram;
• ethics, consent, data availability, funding, conflicts, and author contributions;
• figures, captions, tables, supplements, and permissions;
• a cover letter that explains fit and discloses related work;
• complete author names, affiliations, email, and ORCID records.

Before conversion, compare every number in the abstract, main text, tables, figures, supplements, and registry. A mismatch in the primary outcome is a trust defect, not a formatting detail.

Recent article records help reveal how different kidney-research designs carry their limitations. Useful 2025 examples include 10.1186/s12882-025-04243-8, 10.1186/s12882-025-03972-0, and 10.1186/s12882-025-04521-5. Do not copy their section order. Instead, compare how the patient or specimen population, renal measure, timing, adjustment set, and clinical boundary sit beside the central result.

Then test your own manuscript with one compact trace: population → renal signal → comparison → uncertainty → clinical meaning. Every arrow needs evidence. If the trace skips from an estimated measure to a treatment conclusion, or from a single-center association to a general pathway claim, reduce the conclusion or add the missing validation. This exercise is especially useful when the abstract and discussion currently describe a broader population than the methods actually enrolled.

In our pre-submission review work, nephrology manuscripts most often lose clarity at the boundary between a measured renal signal and the clinical inference attached to it. This is Manusights editorial observation, not access to private BMC decisions.

The CKD population is treated as homogeneous. Stage, cause, comorbidity, dialysis status, transplant status, medication, and care setting can change the meaning of the same result.

Estimated kidney function becomes a direct mechanism. Separate the measurement, biological interpretation, and clinical decision.

A prediction model has no use pathway. Calibration and external validation matter because a high discrimination statistic does not show what clinicians should do.

Missingness and competing risk are invisible. Kidney cohorts often have informative follow-up, death, treatment changes, and incomplete measurement. Put those choices near the result they affect.

BMC Nephrology does not promise a case-specific timeline, so use this as a stage map rather than a forecast.

• Package intake: the journal checks authorship, files, declarations, reporting materials, and the live submission-guideline requirements.
• Editorial assessment: an editor tests whether nephrology owns the question and whether the design can support the clinical or mechanistic claim.
• Peer review: suitable manuscripts are routed to reviewers; ethics, cohort definition, outcomes, statistics, and data availability remain inspectable.
• Revision or decision: authors answer the reports and update every affected manuscript component before a final editorial decision.

If the abstract still outruns the cohort or methods, check the kidney-specific claim one more time.

What research fits BMC Nephrology?

BMC Nephrology publishes research on the prevention, diagnosis, and management of kidney disease and related genetics, pathophysiology, and epidemiology.

Where do I submit to BMC Nephrology?

Use the submission route linked from the current Springer Nature journal page. Verify the live portal and article type before uploading files.

What should I prepare beyond the manuscript?

Prepare the applicable reporting checklist, ethics and consent statements, data availability statement, author contributions, funding, conflicts, figures, tables, supplements, and any article-type-specific files.

Does a kidney cohort automatically fit?

No. The paper should make a nephrology inference that the design can support. A cohort label alone does not replace a clear kidney-disease question, comparator, outcome, and evidence boundary.

Official sources accessed August 21, 2026.

1. BMC Nephrology journal page, Springer Nature.
2. Springer Nature manuscript preparation, Springer Nature.
3. EQUATOR reporting guideline library, EQUATOR Network.
4. BMC Nephrology fees and funding, Springer Nature.
5. BMC Nephrology editorial board, Springer Nature.